Dr. Xiaobing Jiang 蒋小兵
Chief Physician
Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for pituitary tumors and brain metastases. Experience in minimally invasive treatment of gliomas, meningiomas, craniopharyngiomas, and acoustic neuromas.
Dr. Jiang holds a medical degree from Harvard Medical School and serves as Chief Physician and master’s supervisor. The doctor performs approximately 100 pituitary tumor surgeries annually and has extensive experience in comprehensive treatment of refractory pituitary tumors and brain metastases. Dr. Jiang has published over 20 papers in journals including JCEM, Mol Cancer, J Neuro-Oncol, and Pituitary, and leads multiple research projects funded by the National Natural Science Foundation.
Professional roles
- Member, Chinese Pituitary Tumor Collaboration Group
- Member, Neurosurgery Branch of the Chinese Medical Association (Guangdong)
Name order: in Chinese the family name comes first (Jiang Xiaobing). Papers usually list the name as Xiaobing Jiang or Jiang X.
Selected publications
58 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Endocr Disord, 2026 (senior author): Deep learning-based classification of gh-secreting pituitary neuroendocrine tumors granulation patterns using H&E-stained histopathology. PubMed 42436482
- Cancer Biol Med, 2026 (senior author): SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironment. PubMed 41699976
- Med Biol Eng Comput, 2025 (senior author): Reimagining cancer tissue classification: a multi-scale framework based on multi-instance learning for whole slide image classification. PubMed 40088255
- J Genet Genomics, 2025 (senior author): IGF-1-mediated upregulation of gut Blautia correlates with inflammatory markers in growth hormone-secreting pituitary adenomas. PubMed 40320142
- Mol Cell Biochem, 2025 (senior author): Single-cell atlas profiling revealed cellular characteristics and dynamic changes after PD-1 blockade therapy of brain metastases from laryngeal squamous cell carcinoma. PubMed 39085744
- J Clin Endocrinol Metab, 2025 (senior author): Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening. PubMed 38656317
- Mol Cancer, 2024 (senior author): FTO-mediated DSP m(6)A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors. PubMed 39304899
- BMC Endocr Disord, 2024 (senior author): Headache alleviation with nasal irrigation following endoscopic endonasal surgery for pituitary adenomas. PubMed 38622616
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion